Thousands of people with common skin conditions will be able to receive treatment from their pharmacist under the next phase of the NSW Pharmacy Trial, commencing from 12th July.
Eligible people can visit a participating pharmacy to be treated by an appropriately trained pharmacist for impetigo (school sores), shingles, mild to moderate eczema and mild plaque psoriasis.
Under the trial, patients will not have to pay for the consultation, but will pay for the cost of medicines they receive as part of their treatment.
NSW Minister for Health Ryan Park, says with fewer GPs in 2023 than there were in 2018, the government is taking steps to make it easier for people to gain access to simple treatments and medications they need for non-complex conditions.
The trial will close on 28 February 2025, or when the maximum number of trial-supported consultations has been reached.
